Extrudable and Extruded Compositions for Delivery of Bioactive Agents, Method of Making Same and Method of Using Same

• US 20090098192A1
• Filed: 10/10/2008
• Published: 04/16/2009
• Est. Priority Date: 10/11/2007
• Status: Abandoned Application

• Current Assignee: Philip Morris Products SA (Philip Morris Limited)
• Original Assignee: Philip Morris Products SA (Philip Morris Limited)
• Inventors: FUISZ, Richard C.
• Application Number:
  US12/249,456
• Publication Number:
  US 20090098192A1
• Time in Patent Office: Days
• US Class Current: 424/444
• CPC Class Codes: A23G 4/06 characterised by the composition containing organic or inorganic compounds
• CPC Class Codes: A23L 27/74 with a synthetic polymer matrix or excipient, e.g. vinylic, acrylic polymers
• CPC Class Codes: A23L 27/79 in the form of films
• CPC Class Codes: A24B 15/16 of tobacco substitutes
• CPC Class Codes: A61K 31/465 Nicotine; Derivatives thereof
• CPC Class Codes: A61K 31/722 Chitin, chitosan
• CPC Class Codes: A61K 47/585 Ion exchange resins, e.g. polystyrene sulfonic acid resin
• CPC Class Codes: A61K 47/60 the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
• CPC Class Codes: A61K 47/61 the organic macromolecular compound being a polysaccharide or a derivative thereof
• CPC Class Codes: A61K 47/6953 the form being a fibre, a textile, a slab or a sheet
• CPC Class Codes: A61K 9/0056 Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
• CPC Class Codes: A61K 9/006 Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
• CPC Class Codes: A61K 9/1611 Inorganic compounds
• CPC Class Codes: A61K 9/1652 Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin homeopathic globules A61K9/1623

Abstract

A nonaqueous, extrudable composition includes at least one thermoplastic polymer in an amount of more than 20 wt % of the whole composition and tobacco. An extruded bioactive product in the form of a sheet can be made by extruding or hot melt shaping a nonaqueous composition comprising at least one thermoplastic polymer and a bioactive agent, the sheet being soluble in a user'"'"'s mouth and resulting in sustained release of bioactive to the user. The sheet can be in a form that may be placed in contact with the mucosa of the user, and have an average dissolution time of 5 to 50 minutes for delivering the bioactive to the user.

Claims

1. A nonaqueous, extrudable composition comprising at least one thermoplastic polymer in an amount of more than 20 wt % of the whole composition and a bioactive agent other than tobacco, the composition not containing polycarbophil.

2. The nonaqueous, extrudable composition according to claim 1, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, or salts thereof.

3. The nonaqueous, extrudable composition according to claim 1, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, and plasticizer.

4. The nonaqueous, extrudable composition according to claim 1, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, plasticizer and polyethylene oxide.

5. The nonaqueous, extrudable composition according to claim 1, wherein the at least one thermoplastic polymer comprises hydroxypropyl cellulose (HPC).

6. The nonaqueous, extrudable composition according to claim 5, wherein the HPC comprises HPCLF, HPCELF or HPCEF.

7. The nonaqueous, extrudable composition according to claim 1, wherein the at least one polymer comprises at least one polymer selected from the group consisting of cellulose ethers, polyethylene oxide, polymethacrylates, poloxamers, extrudable carbohydrates, polyethylene glycols, PVP, poly vinyl alcohol, acrylates, ethyl cellulose, cellulose acetate butyrate, poly(ethylene-co-vinyl acetate) copolymer, poly vinyl acetate, poly(methylvinyl ether/maleic anhydride) co-polymer, pullulan, hydroxypropyl cellulose (HPC), hydroxypropyl methylcellulose (HPMC), amorphous polysaccharides and polycarbophyl.

8. The nonaqueous, extrudable composition according to claim 1, wherein the at least one thermoplastic polymer comprises polyethylene oxide (PEO).

9. The nonaqueous, extrudable composition according to claim 1, wherein the bioactive agent is a dry powder.

10. The nonaqueous, extrudable composition according to claim 1, wherein the bioactive agent is a nonaqueous liquid.

11. The nonaqueous, extrudable composition according to claim 10, wherein the bioactive agent is simethicone.

12. The nonaqueous, extrudable composition according to claim 1, further comprising a mucosal absorbing enhancer.

13. The nonaqueous, extrudable composition according to claim 12, wherein the mucosal absorbing enhancer is polyethylene glycol.

14. The nonaqueous, extrudable composition according to claim 1, further comprising a buffering agent for controlling a pH of the composition.

15. The nonaqueous, extrudable composition according to claim 14, wherein the buffering agent is present in an amount to provide the composition with a pH of 3 to 9 when the composition is present in a user'"'"'s mouth.

16. The nonaqueous, extrudable composition according to claim 14, wherein the buffering agent is present in an amount to provide the composition with a pH of 6 to 8 when the composition is present in a user'"'"'s mouth

17. The nonaqueous, extrudable composition according to claim 1, wherein the composition includes less than 10 wt % water.

18. The nonaqueous extrudable composition according to claim 1, wherein the bioactive agent is soluble in water.

19. The nonaqueous extrudable composition according to claim 1, wherein the bioactive agent is insoluble in water.

20. The nonaqueous, extrudable composition according to claim 1, further comprising a flavoring agent.

21. The nonaqueous, extrudable composition according to claim 1, further comprising a plasticizer.

22. The nonaqueous, extrudable composition according to claim 21, wherein the plasticizer is present at least one of polypropylene glycol, polyethylene glycol, glycerin, glycerol and a water soluble edible polyol.

23. The nonaqueous, extrudable composition according to claim 22, wherein the plasticizer is present in an amount up to 30% based on the weight of the thermoplastic polymer.

24. The nonaqueous, extrudable composition according to claim 21, wherein the at least one polymer comprises HPC, and the plasticizer comprises polyethylene oxide.

25. The nonaqueous, extrudable composition according to claim 1, wherein the at least one thermoplastic polymer comprises a water soluble polymer.

26. The nonaqueous, extrudable composition according to claim 1, wherein the at least one thermoplastic polymer is contained in an amount of at least 30 wt % of the whole composition.

27. The nonaqueous, extrudable composition according to claim 1, wherein the at least one thermoplastic polymer is contained in an amount up to 50 wt % of the whole composition.

28. The nonaqueous extrudable composition according to claim 1, wherein the bioactive agent includes an ion exchange resin.

29. The nonaqueous extrudable composition according to claim 1, wherein the bioactive agent includes chitosan.

30. An extruded bioactive product comprising a sheet made by extruding or hot melt shaping a nonaqueous composition comprising at least one thermoplastic polymer and a bioactive agent other than tobacco, the composition not containing polycarbophil, the sheet comprising a matrix comprising the at least one thermoplastic polymer and the bioactive agent distributed in the matrix, the matrix being soluble in the mucosa of a user and resulting in sustained release of the bioactive agent to the user.

31. The extruded bioactive product according to claim 30, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, or salts thereof.

32. The extruded bioactive product according to claim 30, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, and plasticizer.

33. The extruded bioactive product according to claim 30, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, plasticizer and polyethylene oxide.

34. The extruded bioactive product according to claim 30, wherein the sheet has a rectangular shape.

35. The extruded bioactive product according to claim 34, wherein the sheet has a thickness of 10 to 50 mils.

36. The extruded bioactive product according to claim 30, wherein the at least one polymer comprises polyethylene oxide (PEO).

37. The extruded bioactive product according to claim 30, wherein the at least one polymer comprises hydroxypropyl cellulose (HPC).

38. The extruded bioactive product according to claim 37, wherein the HPC comprises HPCLF, HPCELF or HPCEF.

39. The extruded bioactive product according to claim 30, wherein the bioactive is in the form of a powder.

40. The extruded bioactive product according to claim 30, wherein the bioactive is in the form of a nonaqueous liquid.

41. The extruded bioactive product according to claim 30, further comprising a mucosal absorbing enhancer.

42. The extruded bioactive product according to claim 30, further comprising a buffering agent for controlling a pH of the composition.

43. The extruded bioactive product according to claim 42, wherein the buffering agent is present in an amount to provide the product with a pH of 2.5 to 9 when the composition is present in the user'"'"'s mouth.

44. The extruded bioactive product according to claim 30, wherein the bioactive agent includes an ion exchange resin.

45. The extruded bioactive product according to claim 44, wherein the bioactive product is in the form of a sheet having a thickness greater than 10 mil.

46. The extruded bioactive product according to claim 30, wherein the bioactive product is in the form of a sheet having a thickness greater than 10 mil.

47. The extruded bioactive product according to claim 30, wherein the bioactive agent includes chitosan.

48. The extruded bioactive product according to claim 30, wherein the extruded composition includes less than 4 wt % water.

49. The extruded bioactive product according to claim 30, further comprising a flavoring.

50. The extruded bioactive product according to claim 30, further comprising a plasticizer.

51. The extruded bioactive product according to claim 50, wherein plasticizer is at least one of polypropylene glycol, polyethylene glycol, glycerin and glycerol.

52. The extruded bioactive product according to claim 51, wherein the plasticizer is present in an amount up to 30% based on the weight of the thermoplastic polymer.

53. The extruded bioactive product according to claim 50, wherein the plasticizer is present in an amount up to 30% based on the weight of the thermoplastic polymer.

54. The extruded bioactive product according to claim 53, wherein the sheet has an average dissolution time of 5 to 50 minutes and a thickness of approximately 10-50 mil, to dissolve in the oral cavity.

55. The extruded bioactive product according to claim 30, wherein the sheet has a tensile strength of at least 4 lbs.

56. The extruded bioactive product according to claim 30, wherein the sheet has a uniformity in the range of ±

10%.

57. The extruded bioactive product according to claim 30, wherein the at least one thermoplastic polymer is contained in an amount of at least 20 wt % of the whole composition.

58. The extruded bioactive product according to claim 30, wherein the at least one thermoplastic polymer comprises a water soluble polymer.

59. The extruded bioactive product according to claim 30, wherein the composition contains less than 80 wt % of the bioactive agent.

60. An extruded bioactive product comprising a nonaqueous composition comprising at least one thermoplastic polymer and a bioactive agent other than tobacco, the composition not containing polycarbophil, in a form that may be placed on mucosal tissue and having an average dissolution time of 5 to 50 minutes, measured for a composition in the form of a sheet having a surface area consequent with comfort and bioactive loading and a thickness of approximately 10-50 mil.

61. The extruded bioactive product according to claim 60, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, or salts thereof.

62. The extruded bioactive product according to claim 60, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, and plasticizer.

63. The extruded bioactive product according to claim 60, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, plasticizer and polyethylene oxide.

64. The extruded bioactive product according to claim 60, wherein the bioactive agent includes an ion exchange resin.

65. The extruded bioactive product according to claim 64, wherein the bioactive product is in the form of a sheet having a thickness greater than 10 mil.

66. The extruded bioactive product according to claim 60, wherein the bioactive product is in the form of a sheet having a thickness greater than 10 mil.

67. The extruded bioactive product according to claim 60, wherein the bioactive agent includes chitosan.

68. The extruded bioactive product according to claim 60, further comprising a flavoring.

69. The extruded bioactive product according to claim 60, wherein the bioactive product is in the form of a sheet

70. The extruded bioactive product according to claim 60, wherein the composition contains less than 50 wt % of the bioactive agent.

71. An extruded bioactive product in the form of an extruded sheet, comprising at least one thermoplastic polymer and a bioactive material comprising a bioactive agent other than tobacco and an ion exchange resin.

72. The extruded bioactive product according to claim 71, wherein the sheet has a thickness greater than 10 mil.

73. A an extruded bioactive nicotine containing product comprising a thermoplastic polymer matrix and nicotine and having a maximum measured nicotine plasma concentration greater than 4 ng/ml when administered in a single dose.

74. A method for making a dosage unit, comprising extruding a nonaqueous composition comprising at least one thermoplastic polymer in an amount of more than 20 wt % the whole composition and a bioactive agent other than tobacco, the composition not containing polycarbophil, through an extruder to form an extruded sheet of the nonaqueous composition.

75. The method according to claim 74, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, or salts thereof.

76. The method according to claim 74, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, and plasticizer.

77. The method according to claim 74, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, plasticizer and polyethylene oxide.

78. The method according to claim 74, wherein the bioactive agent includes an ion exchange resin.

79. The method according to claim 78, wherein the extruded sheet has a thickness greater than 10 mil.

80. The method according to claim 78, wherein a ratio of the bioactive agent to the ion exchange resin is from 0.1:

100 to 100;

0.1.

81. The method according to claim 74, wherein the extruded sheet has a thickness greater than 10 mil.

82. The method according to claim 74, wherein the bioactive agent includes chitosan.

83. The method according to claim 74, wherein the extruding of the composition is carried out without injecting gas into the composition.

84. The method according to claim 74, wherein the at least one polymer comprises polyethylene oxide (PEO).

85. The method according to claim 74, wherein the at least one polymer comprises hydroxypropyl cellulose (HPC).

86. The method according to claim 74, wherein the extruded sheet has a thickness of 10 to 50 mils.

87. The method according to claim 74, wherein the composition is extruded at a temperature sufficiently low and for a time sufficiently short to not degrade the bioactive.

88. The method according to claim 74, wherein the composition is extruded at a temperature of less than 200°

F.

89. The method according to claim 74, wherein the composition is extruded at a temperature of 350°

F. or lower and for a time of 2 minutes or less.

90. The method according to claim 74, wherein the composition is extruded at a temperature of 400°

F. or lower and for a time of 2 minutes or less.

91. The method according to claim 74, wherein the nonaqueous composition further comprises flavoring.

92. The method according to claim 91, wherein the nonaqueous composition flavoring is in liquid form and the extruder is vented.

93. The method according to claim 74, wherein the extruder is vented.

94. The method according to claim 74, the nonaqueous composition further comprises a plasticizer.

95. The method according to claim 94, wherein plasticizer is at least one of polypropylene glycol, polyethylene glycol, glycerin, glycerol and a water soluble edible polyol.

96. The method according to claim 95, wherein the plasticizer is present in an amount up to 30% based on the weight of the thermoplastic polymer.

97. The method according to claim 94, wherein the plasticizer is present in an amount up to 30% based on the weight of the thermoplastic polymer.

98. The method according to claim 74, further comprising cutting the extruded sheet to form a plurality of smaller sheets.

99. The method according to claim 98, wherein each of the smaller sheets has a rectangular thin strip shape or an ovoid shape.

100. The method according to claim 99, wherein the sheet has a rectangular thin strip shape having a length of 1/16 inch to 4 inches long, a width of 1/16 inch to 4 inches and a thickness of 5 to 50 mils.

101. The method according to claim 98, further comprising recycling any discarded portions of the extruded sheet to an inlet of the extruder.

102. The method according to claim 74, further comprising winding the extruded sheet about a roll to form a roll of the extruded sheet.

103. The method according to claim 74, further comprising passing the extruded sheet around a portion of at least one roller.

104. The method according to claim 103, wherein the at least one roller is smooth or textured.

105. The method according to claim 74, further comprising passing the extruded sheet between two rollers to provide the extruded sheet with a thickness corresponding to a distance between the two rollers.

106. The method according to claim 74, further comprising controlling a thickness of the extruded sheet by monitoring the thickness of the extruded sheet using a thickness gauge, and controlling a feeder feeding the extruder and a pressure of a pump to pump the nonaqueous composition through a die on the basis of the monitored thickness.

107. The method according to claim 103, wherein the at least one roller is graveured to provide a design on a surface on at least one side of the extruded sheet.

108. The method according to claim 74, wherein the extruder is a single screw extruder.

109. The method according to claim 108, wherein the nonaqueous composition is extruded through the single screw extruder.

110. The method according to claim 74, wherein the extruder is a double screw extruder with a pump to pump the nonaqueous composition through a die thereof at constant pressure.

111. The method according to claim 74, wherein the extruder comprises a die and a pump to control pressure on the die.

112. The method according to claim 74, wherein the composition is exposed to heat in processing for less than 90 seconds.

113. A method for delivering nicotine from a bioactive product to a user, comprising:

providing a sheet of a bioactive product comprising an extruded nonaqueous composition comprising at least one thermoplastic polymer and nicotine; and

placing the sheet in the buccal cavity of, on the palate of or sublingually in the user.

114. The method according to claim 113, further comprising folding the sheet at approximately a mid-point of its length to form a V-shaped folded sheet before placing the sheet in the buccal cavity.

115. The method according to claim 113, wherein the nonaqueous composition comprises a breath freshening material and the method induces freshened breath in the user for an extended period.

116. The method according to claim 113, wherein the composition does not contain polycarbophil.

117. The method according to claim 113, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, or salts thereof.

118. The method according to claim 113, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, and plasticizer.

119. The method according to claim 113, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, plasticizer and polyethylene oxide.

120. A method for administering a clotting agent, comprising:

providing a sheet of a bioactive product comprising an extruded nonaqueous composition comprising at least one thermoplastic polymer and a clotting agent; and

placing the sheet on or in a wound user.

121. The method according to claim 120, wherein the clotting agent is chitosan.

122. The method according to claim 120, wherein the composition does not contain polycarbophil.

123. The method according to claim 120, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, or salts thereof.

124. The method according to claim 120, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, and plasticizer.

125. The method according to claim 120, wherein the composition does not contain polycarbophil, carbomer, acrylic polymers, polyacrylic acids, copolymers of these polymers, a water soluble salt of a co-polymer of methyl vinyl ether and maleic acid or anhydride, and salts thereof, plasticizer and polyethylene oxide.

126. A single use package, comprising sheet of a bioactive product comprising an extruded nonaqueous composition comprising at least one thermoplastic polymer and a bioactive agent other than tobacco, the sheet being of a size to administer a single dose of the bioactive agent to a user, and a package in which the sheet is sealed.